-
11.发明公开公开(公告)号：US20230207137A1
公开(公告)日：2023-06-29
申请号：US18115924
申请日：2023-03-01
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G16H50/50 , G06T7/0012 , G16B5/00 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
-
12.发明申请公开(公告)号：US20230005583A1
公开(公告)日：2023-01-05
申请号：US17838147
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
13.发明申请公开(公告)号：US20220400963A1
公开(公告)日：2022-12-22
申请号：US17838129
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
-
14.发明授权公开(公告)号：US11887701B2
公开(公告)日：2024-01-30
申请号：US17838146
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230420143A1
公开(公告)日：2023-12-28
申请号：US18240190
申请日：2023-08-30
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G16H50/50 , G06T7/0012 , G16B5/00 , G16H50/70 , G16H20/10 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.
-
Patent Agency Ranking
公开(公告)号：US20230420130A1
公开(公告)日：2023-12-28
申请号：US18241718
申请日：2023-09-01
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
17.发明公开公开(公告)号：US20230386633A1
公开(公告)日：2023-11-30
申请号：US18232138
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
18.发明申请公开(公告)号：US20220415519A1
公开(公告)日：2022-12-29
申请号：US17838135
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
19.发明授权公开(公告)号：US12125571B2
公开(公告)日：2024-10-22
申请号：US18232138
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
20.发明授权公开(公告)号：US12100149B2
公开(公告)日：2024-09-24
申请号：US18232246
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G06T7/0012 , A61B5/055 , G16B5/00 , G16C20/30 , G16H20/00 , G06T2207/10088 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
-
-
-
-
-
-
-
-
Search Results
28
records
(took 0.016 seconds)
